Intraday MarketsStock report · GH · Guardant Health, Inc. · Nov 2, 2026
Intraday Markets
Home › Stocks › GH

GH Stock: Price, Earnings History and SEC Filings

Guardant Health, Inc. (GH) last traded at $178.80, down 3.51% on the latest session and up 0.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.89 against an analyst estimate of $-0.74, a miss of 20.3%.

$178.80 -3.51%
1 month+0.25%
52-week high$191.05
52-week low$74.55
Volume1.50M
ExchangeNasdaqGS

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

GH earnings history

QuarterReportedEPSEstimateSurprise
Jun 2026Jul 30, 2026$-0.89$-0.74-20.27%
Mar 2026May 7, 2026$-0.85$-0.71-19.72%
Dec 2025Feb 19, 2026$-1.00$-0.81-23.46%
Sep 2025Oct 29, 2025$-0.74$-0.80+7.50%

GH beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.

How GH reacts to earnings

Across its last 8 earnings releases, GH moved 8.2% on average the next session, in either direction. It rose after 4 of 8 reports.

Report dateReleasedNext-session move
2026-07-30After close+6.33%
2026-05-07After close+3.73%
2026-02-19After close-3.08%
2026-01-12Before open-2.36%
2025-10-29After close+27.87%
2025-07-30After close-9.32%
2025-04-30After close+3.47%
2025-02-20After close-9.56%

Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.

GH financial history

Revenue
$91M2018$214M2019$287M2020$374M2021$450M2022$564M2023$739M2024$982M2025
Net income
-$85M2018-$76M2019-$385M2021-$655M2022-$479M2023-$436M2024-$416M2025
Free cash flow
-$92M2018-$66M2019-$140M2020-$284M2021-$387M2022-$345M2023-$275M2024-$233M2025
Fiscal yearRevenueNet incomeFree cash flowNet marginDiluted EPS
2025$982M-$416M-$233M-42.4%$-3.32
2024$739M-$436M-$275M-59.0%$-3.56
2023$564M-$479M-$345M-85.0%$-4.28
2022$450M-$655M-$387M-145.6%$-6.41
2021$374M-$385M-$284M-103.0%$-4.00
2020$287M–-$140M–$-2.60
2019$214M-$76M-$66M-35.3%$-0.84
2018$91M-$85M-$92M-93.8%–

Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.

Latest SEC filings for GH

Insider filing activity

GH insiders filed 33 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.

Source: SEC EDGAR.

GH news

About Guardant Health, Inc.

Guardant Health, Inc. (GH) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-medical Laboratories. It is incorporated in DE. Its fiscal year ends in December.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed